Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism

Psychiatry Research - Neuroimaging

Volumn 82, Issue 2, 1998, Pages 69-82

  Streeter, Chris C ^a,b,c   Ciraulo, Domenic A ^a   Harris, Gordon J ^a,b,c   Kaufman, Marc J ^b   Lewis, Robert F ^c   Knapp, Clifford M ^a   Ann Marie Ciraulo, ^a   Maas, Luis C ^b   Ungeheuer, Michelle ^a   Szulewski, Susan ^a   Renshaw, Perry F ^b  

^a Department of Psychiatry 116A   (United States)

^b MCLEAN HOSPITAL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Alprazolam; Benzodiazepine; Functional imaging; MRI

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; GADOTERIDOL; MORPHINE; PLACEBO;

ADULT; ALCOHOLISM; ARTICLE; BRAIN BLOOD FLOW; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOOD; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADULT; AFFECT; ALCOHOLISM; ALPRAZOLAM; ANTI-ANXIETY AGENTS; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ECHO-PLANAR IMAGING; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE;

EID: 7344263525     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(98)00009-2     Document Type: Article

References (47)

1. Andreasen N.C., Endicott J., Spitzer R.L., Winokur G. The family history method using diagnostic criteria: reliability and validity. Archives of General Psychiatry. 34:1977;1229-1235.
2. Belliveau J.W., Rosen B.R., Kantor H.L., Rzedzian R.R., Kennedy D.N., McKinstry R.C., Vevea J.M., Cohen M.S., Pykett I.L., Brady T.J. Functional cerebral imaging by susceptibility-contrast NMR. Magnetic Resonance in Medicine. 14:1990;538-546.
3. Buchsbaum M.S., Wu J.C., Haier R.J., Hazlett E., Ball R., Katz M., Sokolski K., Lagunas-Solar M., Langer D.H. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sciences. 40:1987;2393-2400.
4. Ciraulo D., Sarid-Segal O., Knapp C., Ciraulo M., Greenblatt D., Shader R. Liability to alprazolam abuse in daughters of alcoholics. American Journal of Psychiatry. 153:1996;956-958.
5. Ciraulo D.A., Barnhill J.G., Ciraulo A.M., Greenblatt D.J., Shader R.I. Parental alcoholism as a risk factor in benzodiazepine abuse: a pilot study. American Journal of Psychiatry. 146:1989;1333-1335.
6. Ciraulo, D.A., Greenblatt, D.J., 1995. Sedative-, hypnotic-, anxiolytic-related disorders. In: Kaplan, H.I., Sadock, B.J. (Eds.), Comprehensive Textbook of Psychiatry/VI. Williams and Wilkens, Baltimore, MD, pp. 872-887.
7. Ciraulo D.A., Sands B.F., Shader R.I. Critical review of liability for benzodiazepine abuse among alcoholics. American Journal of Psychiatry. 145:1988;1501-1506.
8. Cloninger C., Bohman M., Sigvardsson S. Inheritance of alcohol abuse. Archives of General Psychiatry. 38:1981;965-969.
9. Cowley D.S., Roy-Byrne P.P., Godon C., Greenblatt D.J., Ries R., Walker R.D., Samson H.H., Hommer D.W. Response to diazepam in sons of alcoholics. Alcoholism: Clinical and Experimental Research. 16:1992;1057-1063.
10. de Wit H., Metz J., Wagner N., Cooper M. Effects of diazepam on cerebral metabolism and mood in normal volunteers. Neuropsychopharmacology. 5:1991;33-41.
11. Evans S.M., Critchfield T.S., Griffiths R.R. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore. British Journal of Addiction. 86:1991;1625-1632.
12. Folstein, S.E., 1989. Chapter 5. Neuroscience. In: Folstein, S.E. (Eds.), Huntington's Disease: A Disorder of Families. The Johns Hopkins University Press, Baltimore and London, pp. 67-87.
13. Forster A., Juge O., Morel D. Effects of midazolam on cerebral blood flow in human volunteers. Anesthesiology. 56:1982;454-455.
14. Foster N.L., VanDerSpek A.F.L., Aldrich M.S., Berent S., Hichwa R.H., Sackellares J.C., Gilman S., Agranoff B.W. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism. 7:1987;415-420.
15. Gagnon, J., Haycock, K., Roth, J., Feldman, D., Finzer, W. 1989. SuperANOVA, Accessible General Linear Modeling. Abacus Concepts, Berkeley, CA.
16. Gonzalez G., Fischman A., Gulmaraes A., Carr C., Stern C., Halpern E., Growdon J., Rosen B. Functional MR in the evaluation of dementia: correlations of abnormal dynamic cerebral blood volume measures with changes in cerebral metabolism in positron emission tomography with fluorodeoxyglucose F18. American Journal of Neuroradiology. 16:1995;1763-1770.
17. Gorelick, D.A., 1998. The rate hypothesis and agonist substitutions approaches to cocaine abuse treatment. In: Goldstein, D., Eisenhofer, G., McCarthy, R. (Eds.), Catecholamines: Bridging Basic Science with Clinical Medicine. (Advances in Pharmacology: 42), Academic Press, New York, pp. 995-997.
18. Greenblatt D., Bigelow G., Locniskar A. Gas chromatographic analysis of alprazolam in plasma. Journal of Chromatography. 534:1990;202-207.
19. Griffith R.R., McLeod D.R., Bigelow G.E., Liebson I.A., Roache J.D., Nowowioski P. Comparison of diazepam and oxazepam: preference, liking and extent of abuse. Journal of Pharmacology and Experimental Therapeutics. 229:1984;501-508.
20. Haertzen C.A. Addiction Research Center Inventory (ARCI); development of a general drug estimation scale. Journal of Nervous and Mental Disease. 141:1965;300-307.
21. Harris G.J., Lewis R.F., Satlin A., English C.D., Scott T.M., Yurgelun-Todd D.A., Renshaw P.F. Dynamic susceptibility contrast magnetic resonance imaging of regional cerebral blood volume in Alzheimer's disease. American Journal of Psychiatry. 153:1996;721-724.
22. Harris G.J., Links J.M., Pearlson G.D., Camargo E.E. Cortical circumferential profile of SPECT cerebral perfusion in Alzheimer's disease. Psychiatry Research: Neuroimaging. 40:1991;167-180.
23. Harris, G.J., Hoehn-Saric, R., 1995. Functional neuroimaging in biological psychiatry. In: Panksepp, J. (Eds.), Advances in Biological Psychiatry, vol. 1. JAI Press, Greenwich, pp. 113-160.
24. Haycock, K., Roth, J., Gagnon, J., Finzer, W., Soper, C. 1984. StatView. Abacus Concepts, Inc., Berkeley, CA.
25. Hoffman W.E., Miletich D.J., Albrecht R. Dose and time dependent cerebrovascular and metabolic effects of ethanol. Alcohol. 3:1986;23-26.
26. Hutner N., Oscar-Berman M. Visual lateralization pattern for the perception of emotional words in alcoholics and aging individuals. Journal of Studies on Alcohol. 57:1996;144-154.
27. Kendler K.S., Neale M.C., Heath A.C., Kessler R.C., Eaves L.J. A twin-family study of alcoholism in women. American Journal of Psychiatry. 151:1994;707-714.
28. Levin, J., Ross, M., Mendelson, J.H., Kaufman, M., Cohen, B.M., Renshaw, P.F., 1995a. Reduction in BOLD response to photic stimulation after ethanol administration. Proceedings of the Society of Magnetic Resonance Third Scientific Meeting and Exhibition, Nice, France.
29. Levin J., Kaufman M., Ross M., Mendelson J., Maas L., Cohen B., Renshaw P.F. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magnetic Resonance in Medicine. 34:1995;655-663.
30. Maas L., Frederick B., Renshaw P. Decoupled automated rotational and translational registration for functional MRI time series data: the DART registrational algorithm. Magnetic Resonance in Medicine. 37:1997;131-139.
31. Mathew R.J., Wilson W.H. The effect of nonsedating doses of diazepam on cerebral blood flow. Biological Psychiatry. 20:1985;1109-1116.
32. Mathew R.J., Wilson W.H. Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow. Psychiatry Research: Neuroimaging. 40:1991;125-134.
33. Matthew E., Andreason P., Pettigrew K., Carson R.E., Herscovitch P., Cohen R., King C., Johanson C., Greenblatt D.J., Paul S.M. Benzodiazepine receptors mediate regional blood flow changes in the living human brain. Proceedings of the National Academy of Sciences of the United States of America. 92:1995;2775-2779.
34. Modell J.G., Mountz J.M. Basal ganglia/limbic striatal and thalamocortical involvement in craving and loss of control in alcoholism. Journal of Neuropsychiatry and Clinical Neurosciences. 2:1990;123-144.
35. Modell J.G., Mountz J.M. Focal cerebral blood flow changes during craving for alcohol measured by SPECT. Journal of Neuropsychiatry and Clinical Neurosciences. 7:1995;15-22.
36. Modell J.G., Mountz J.M., Curtis G.C., Greden J.F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenic mechanism of obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences. 1:1988;27-36.
37. Newlin D.B., Thomson J.B. Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychological Bulletin. 108:1990;383-402.
38. Ritchie, J., 1980. The aliphatic alcohols. In: Gilman, A.C., Goodman, L.S., Gilman, A. (Eds.), Goodman and Gilman's, The Pharmacological Basis of Therapeutics. Macmillan Publishing Co., New York, pp. 376-390.
39. Roy-Byrne P., Fleishaker J., Arnett C., Dubach M., Stewart J., Radant A., Veith R., Graham M. Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation and plasma catecholamines. Neuropsychopharmacology. 8:1993;161-169.
40. Schuckit M.A., Duthie L.A., Mahler H.I., Irwin M.R., Monteiro M.G. Subjective feelings and changes in body sway following diazepam in sons of alcoholics and controls. Journal of Studies on Alcohol. 52:1991;601-608.
41. Schuckit M.A. Reaction to alcohol in sons of alcoholics and controls. Alcoholism: Clinical and Experimental Research. 12:1988;465-470.
42. Spielberger, C.D., Gorsuch, R.L., Lushene, R.E., 1970. Manual for State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA.
43. Spitzer, R.L., Williams, J.B.W., Gibbon, M., First, M.B., 1990. Structured Clinical Interview for DSM-IIIR. American Psychiatric Press, Washington, D.C.
44. Talairach, J., Tournoux, P., 1988. Co-planar Stereotaxic Atlas of the Human Brain: Three-Dimensional Proportional System: An Approach to Cerebral Imaging. Thieme Medical Publishers, New York.
45. Ticku M.K., Kulkarni F. Molecular interactions of ethanol with the GABAergic system and potential of R015-4513 as an ethanol antagonist. Pharmacology, Biochemistry and Behaviour. 30:1988;501-510.
46. Volkow N.D., Wang G., Hitzemann R., Fowler J.S., Wolf A.P., Pappas N., Biegon A., Dewey S.L. Decreased cerebral response to inhibitory neurotransmission in alcoholics. American Journal of Psychiatry. 150:1993;417-422.
47. Volkow N., Wang G., Begleiter H., Hitzemann R., Pappas N., Burr G., Pascani K., Wong C., Fowler J., Wolf A. Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. Alcoholism: Clinical and Experimental Research. 19:1995;510-516.